Patients with multiple metabolic risk factorstype 2 diabetes, a strong family history of obesity, or genetic variants associated with appetite dysregulationtypically benefit from long-term therapy
168 However, the possibility of DDIs related to delayed gastric emptying cannot be excluded, 175 so investigators recommend monitoring when oral drugs are co-administered with GLP-1 RAs and a dual GLP-1/GIP RA
I voted yes because its time to put this decision back in the hands of the patient, the physician and the pharmacist, said David Pope, chief pharmacy officer of Xifin Pharmacy Solutions
It is also being studied for: Primary generalized tonic-clonic seizures Major depressive disorder Bipolar depression Potential advantages Once-daily oral capsule No dose titration is required before reaching the target dose
oral, semaglutide vs
Contraindications include: Active seizure disorder or history of seizures Anorexia nervosa or bulimia nervosa (current or past) Abrupt alcohol withdrawal or sedative withdrawal Concurrent use of MAOIs These contraindications apply regardless of whether GLP-1 is being used
